prof. MUDr. Michal Mego, DrSc.
Vedecko/umelecko-pedagogická charakteristika:
Najvýznamnejšie výstupy tvorivej činnosti:
1. | Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer - clinical applications. Nature Reviews - Clinical Oncology. 2010 | Q1 | IF 10,787 |
2. | Mego M, De Giorgi U, Dawood S, Wang X, Valero V, Andreopoulou E, Handy B, Ueno NT, Reuben JM, Cristofanilli M. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. International Journal of Cancer. 2011 | Q1 | IF 5,444 |
3. | Mego M, Mani SA, Lee BN, Li C, Evans KW, Cohen EN, Gao H, Jackson SA, Giordano A, Hortobagyi GN, Cristofanilli M, Lucci A, Reuben JM. Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy. International Journal of Cancer. 2012 | Q1 | IF 6,198 |
4. | Cierna Z, Mego M, Miskovska V, Machalekova K, Chovanec M, Svetlovska D, Hainova K, Rejlekova K, Macak D, Spanik S, Ondrus D, Kajo K, Mardiak J, Babal P. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors. Annals of Oncology. 2016 | Q1 | IF 11,855 |
5. | Mego M, Kalavska K, Karaba M, Minarik G, Benca J, Sedlackova T, Gronesova P, Cholujova D, Pindak D, Mardiak J, Celec P. Plasma Nucleosomes in Primary Breast Cancer. Cancers (Basel). 2020 | Q1 | IF 6,639 |